Ensysce Biosciences, Inc.
- ENSC
- NASDAQ
- Biotechnology
- Pain Drugs
- Abuse-Deterrent Opioids
- Clinical-stage Pharma
$0.52
Today −13.31%Quote Oct 16, 2026, 08:00 PM UTC
+14.54%over the last month
Max drawdown −13.8%From 1-month high −13.3%3 months +92.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$10.1M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$0.49
5.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ENSCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
9